Bids Are Invited For Possible Acquisition Of Chemotherapy Drugs, Aiming To Meet The Needs Of The General Directorate Of Health, In Accordance With The Conditions And Specifications Contained In This Terms Of Reference And The Notice, Under The Aegis Of Law No. 14,133/2021.

Pharmacological Group: Antineoplastics, Active Ingredient: Dacarbazine, Pharmaceutical Form: Injectable Lyophilic Powder, Concentration/Dosage: 200, Unit: Mg, Volume: Not Applicable, Presentation: Ampoule Vial, Accessory: Not Applicable, Active Ingredient: Oxaliplatin, Concentration/Dosage: 100, Active Ingredient: Paclitaxel, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 6, Unit: Mg/Ml, Volume: 5Ml, Active Ingredient: Trastuzumab, Concentration / Dosage: 440, Accessory: Diluent, Active Ingredient: Letrozole, Pharmaceutical Form: Coated Tablet, Concentration / Dosage: 2, 5, Presentation: Not Applicable, Volume: 16, 7Ml, Accessory: N/A, Active Ingredient: Regorafenib, Pharmaceutical Form: Tablet, Concentration / Dosage: 40, Volume: N/A, Presentation: N/A, Active Ingredient: Pertuzumab, Concentration / Dosage: 30, Volume: 14, Presentation: Ampoule Bottle, Supply Form: Unit, Active Ingredient: Trastuzumab Emtansine, Concentration / Dosage: 20, Pharmacological Group: Antineoplastic/Antimemetabolic, Active Ingredient: Pegylated Liposomal Doxorubicin, Pharmaceutical Form: Injectable Suspension, Volume: 10 Ml, Accessory: Na, Concentration / Dosage: 50, Pharmacological Group: Antineoplastic, Active Ingredient: Olaparib, Concentration/Dosage: 150, Pharmacological Group: Antineoplastics/Hormones, Enzyme And Hormonal Action Inhibitors, Active Ingredient: Ribociclib, Presentation: Tablet